NewsBenzinga스크라이브 테라퓨틱스, 미국심장협회 학술 세션에서 3개 임상 프로그램 데이터 발표 예정 스크라이브 테라퓨틱스, 미국심장협회 학술 세션에서 3개 임상 프로그램 데이터 발표 예정 Benzinga 2026.11.04 13:06 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 Ex-Carlyle Executive Launches Asia Secondaries Firm as $3 Trillion Sits Locked in Private Funds 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report